Chimeric antigen receptor (CAR) therapies utilize engineered receptors that are able to redirect immune cells to identify and destroy cancer cells that express a specific antigen. At present, CAR-T ...
The need for effective adjuvant therapies and evidence that the immune system plays a prominent role in the development and progression of melanoma (Curiel-Lewandrowski & Demierre, 2000) have led to ...
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital ...